Abstract

conclusive. The aim of this study was to assess the incremental cost-effectiveness ratio (ICER) of the communitywide application of fluoride varnish in the prevention of early childhood caries (ECC) in non-fluoridated areas. Materials and methods: A cost-effectiveness analysis was carried out based on a clinical decision tree from the payer’s perspective. The effectiveness and cost of the varnish were determined from a two-year follow-up tripleblind randomized control trial in 275 two- to three-year-old children. Costs and benefits were discounted at 3% per year. Only direct costs were evaluated, expressed in Chilean pesos (CLP) valued in July, 2019 (exchange rate USD=CLP686.06). A univariate deterministic sensitivity analysis was carried out. Results: Incidence of ECC was 45 % for the varnish group and 55.6 % for the placebo group with a two-year follow-up. The weighted cost to intervene and treat the consequences of ECC was CLP 67,757 (USD98.76) for the fluoride varnish and CLP 67,739 (USD98.74) for the control group. The ICER was CLP 173 (USD0.25) for each extra healthy child in favor of fluoride varnish. The sensitivity analysis showed that the increase in caries was the variable which most influenced the ICER. Conclusions: The protocol that included fluoride varnish is more effective and less costly in the prevention of ECC in non-fluoridated areas, compared with a placebo. Clinical significance: Findings support the application of fluoride varnish as a cost-effective community strategy to prevent ECC in non-fluoridated areas.